참고문헌 (21)

1. Yoon SH, Ryu BH, Ryu KW, Kim JS. Evaluation for therapeutic effectiveness of Banwhasashim-tang in functional dyspepsia. J Int Korean Med 2003;24(2):329-36. 

2. Park JW, Ryu BH, Yeo IK, Jerng UM, Han GJ, Oh SH, et al. Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled, two-center trial. Trials 2010;11(1):1-7. 

3. Xu G. Treatment of reflux laryngopharyngitis with modified banxia xiexin tang (Pinellia decoction for draining the heart)--a report of 40 cases. Journal of traditional Chinese medicineChung i tsa chih ying wen pan 2006;26(2):127-31. 

4. Shin MR, An HJ, Seo BI, Roh SS. Anti-apoptotic effect of banhasasim-tang on chronic acid reflux esophagitis. World journal of gastroenterology 2017;23(25):4644-53. 

   상세보기

5. Wang Y, Wei W. Clinical Observation of Reflux Esophagitis Treated with Modified BanxiaXiexin Decoction and Rabeprazole. World Journal of Integrated Traditional and Western Medicine 2013;8(2):200-2. 

6. Kim YJ, Hwang BD. Factors affecting medicines expenditure costs-Using Korean medical panel data. Jour of Ko Con A 2018;18(4):664-76. 

7. Song KH. Functional dyspepsia. Korean Journal of Psychosomatic Medicine 2016;24(1):3-8. 

8. Oh JH, Kwon JG. Functional dyspepsia. The Korean Journal of Gastroenterology 2019;73(2):77-83. 

   상세보기

9. Baek KY, Kim SJ, Kim JB, Lee JH, Moon SO, Lee HD, et al. Comparison of marker components and biological activities of socheongryong-tang by different extract methods. Korean Journal of Pharmacognosy 2018;49(4):349-61. 

10. Lee SY, Choi SC, Cho YK, Choi MG. Validation of the Nepean dyspepsia index-Korean version. Kor J Neurogastroenterol Mot 2003;9(suppl):48S. 

11. Choi JY, Bae GE, Shim SH, Seo HJ, Seo HB, Choi JY, et al. Correlation study between electrogastrography and Nepean Dyspepsia Index (NDI) in clinical practice students. J Int Korean Med 2018;39(4):732-40. 

12. Lee OY. Gastrointestinal motility modulating drugs. Journal of the Korean Medical Association 2009;52(9):920-7. 

13. Stolfi C, De Simone V, Pallone F, Monteleone G. Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer. International journal of molecular sciences 2013;14(9):17972-85. 

    상세보기

14. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. The American journal of gastroenterology 1999;94(9):2390-7. 

    상세보기

15. Arinton IG, Samudro P, Sutrisna E, Wibawa I. Randomized clinical trial of omeprazole and ranitidine using Indonesian translated Nepean Dyspepsia Index. J Intern Med 2006;7:170-7. 

16. Hashash JG, Abdul-Baki H, Azar C, Elhajj II, El Zahabi L, Chaar HF, et al. Clinical trial: a randomized controlled cross-over study of flupenthixol+ melitracen in functional dyspepsia. Alimentary pharmacology & therapeutics 2008;27(11):1148-55. 

    상세보기

17. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Alimentary pharmacology & therapeutics 1999;13(2):225-35. 

18. Shin HW, Chung SJ. Drug-induced parkinsonism. Journal of clinical neurology 2012;8(1):15-21. 

    상세보기

19. Shim YH, Park JY, Choi WW, Min IK, Park SU, Jung WS, et al. Herbal medicine treatment for drug-induced parkinsonism. The Journal of Alternative and Complementary Medicine 2015;21(5):273-80. 

    상세보기

20. Cho YK, Choi MG, Kim SH, Lee IS, Kim SW, Chung IS, et al. The effect of mosapride on quality of life in functional dyspepsia. The Korean journal of gastroenterologyTaehan Sohwagi Hakhoe chi 2004;43(3):160-7. 

21. Lee JW, Youn YH, Choi SC, Lee KJ, Kim NY. Multicenter, randomized, placebo-controlled trial to evaluate the efficacy and safety of a controlled-release, once-daily UIC201609/UIC201610 combination therapy for functional dyspepsia: Preliminary study. Korean J Gastroenterol 2021;77(4):171-8. 

저자의 다른 논문 :

김철현 (31)